2024 ICD-10-CM Diagnosis Code T46.6X2D

Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter

ICD-10-CM Code:
T46.6X2D
ICD-10 Code for:
Poisn by antihyperlip and antiarterio drugs, self-harm, subs
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:

Code Classification

  • Injury, poisoning and certain other consequences of external causes
    (S00–T88)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
      (T36-T50)
      • Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system
        (T46)

T46.6X2D is a billable diagnosis code used to specify a medical diagnosis of poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

T46.6X2D is a subsequent encounter code, includes a 7th character and should be used after the patient has completed active treatment for a condition like poisoning by antihyperlipidemic and antiarteriosclerotic drugs intentional self-harm. According to ICD-10-CM Guidelines a "subsequent encounter" occurs when the patient is receiving routine care for the condition during the healing or recovery phase of treatment. Subsequent diagnosis codes are appropriate during the recovery phase, no matter how many times the patient has seen the provider for this condition. If the provider needs to adjust the patient's care plan due to a setback or other complication, the encounter becomes active again.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Clofibrate overdose
  • Gamolenic acid overdose
  • Intentional clofibrate overdose
  • Intentional clofibrate poisoning
  • Intentional gamolenic acid overdose
  • Poisoning by clofibrate
  • Poisoning by clofibrate

Clinical Classification

Clinical CategoryCCSR Category CodeInpatient Default CCSROutpatient Default CCSR
Poisoning by drugs, subsequent encounterINJ059N - Not default inpatient assignment for principal diagnosis or first-listed diagnosis.N - Not default outpatient assignment for principal diagnosis or first-listed diagnosis.
Suicide attempt/intentional self-harm; subsequent encounterMBD027Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.

Clinical Information

  • Bezafibrate

    an antilipemic agent that lowers cholesterol and triglycerides. it decreases low density lipoproteins and increases high density lipoproteins.
  • Clofibrate

    a fibric acid derivative used in the treatment of hyperlipoproteinemia type iii and severe hypertriglyceridemia. (from martindale, the extra pharmacopoeia, 30th ed, p986)
  • Colestipol

    highly crosslinked and insoluble basic anion exchange resin used as anticholesteremic. it may also may reduce triglyceride levels.
  • Fenofibrate

    an antilipemic agent which reduces both cholesterol and triglycerides in the blood.
  • Gemfibrozil

    a lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol.
  • Halofenate

    an antihyperlipoproteinemic agent and uricosuric agent.
  • Linoleic Acid

    a doubly unsaturated fatty acid, occurring widely in plant glycosides. it is an essential fatty acid in mammalian nutrition and is used in the biosynthesis of prostaglandins and cell membranes. (from stedman, 26th ed)
  • Linoleic Acids

    eighteen-carbon essential fatty acids that contain two double bonds.
  • Linoleic Acids, Conjugated

    a collective term for a group of around nine geometric and positional isomers of linoleic acid in which the trans/cis double bonds are conjugated, where double bonds alternate with single bonds.
  • Linoleoyl-CoA Desaturase

    an enzyme that catalyzes the syn-dehydrogenation of linoleol-coa gamma-linolenoyl-coa. it was formerly characterized as ec 1.14.99.25.
  • Lovastatin

    a fungal metabolite isolated from cultures of aspergillus terreus. the compound is a potent anticholesteremic agent. it inhibits 3-hydroxy-3-methylglutaryl coenzyme a reductase (hydroxymethylglutaryl coa reductases), which is the rate-limiting enzyme in cholesterol biosynthesis. it also stimulates the production of low-density lipoprotein receptors in the liver.
  • Oleic Acid

    an unsaturated fatty acid that is the most widely distributed and abundant fatty acid in nature. it is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent. (stedman, 26th ed)
  • Oleic Acids

    a group of fatty acids that contain 18 carbon atoms and a double bond at the omega 9 carbon.
  • Ricinoleic Acids

    eighteen carbon fatty acids that comprise the great majority of castor oil, which is from the seed of ricinus.
  • Pravastatin

    an antilipemic fungal metabolite isolated from cultures of nocardia autotrophica. it acts as a competitive inhibitor of hmg coa reductase (hydroxymethylglutaryl coa reductases).
  • Probucol

    a drug used to lower ldl and hdl cholesterol yet has little effect on serum-triglyceride or vldl cholesterol. (from martindale, the extra pharmacopoeia, 30th ed, p993).
  • Safflower Oil

    an oily liquid extracted from the seeds of the safflower, carthamus tinctorius. it is used as a dietary supplement in the management of hypercholesterolemia. it is used also in cooking, as a salad oil, and as a vehicle for medicines, paints, varnishes, etc. (dorland, 28th ed & random house unabridged dictionary, 2d ed)
  • Simvastatin

    a derivative of lovastatin and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase (hydroxymethylglutaryl coa reductases), which is the rate-limiting enzyme in cholesterol biosynthesis. it may also interfere with steroid hormone production. due to the induction of hepatic ldl receptors, it increases breakdown of ldl cholesterol.
  • Sitosterols

    a family of sterols commonly found in plants and plant oils. alpha-, beta-, and gamma-isomers have been characterized.
  • Triparanol

    antilipemic agent with high ophthalmic toxicity. according to merck index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts.

Coding Guidelines

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined. If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system (T46). Use the following options for the aplicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Present on Admission (POA)

T46.6X2D is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

POA IndicatorReason for CodeCMS will pay the CC/MCC DRG?
YDiagnosis was present at time of inpatient admission.YES
NDiagnosis was not present at time of inpatient admission.NO
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.NO
WClinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.YES
1Unreported/Not used - Exempt from POA reporting. NO

Convert T46.6X2D to ICD-9-CM

  • ICD-9-CM Code: V58.89 - Other specfied aftercare
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Table of Drugs and Chemicals

The parent code T46.6X2 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.

According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.

Substance Poisoning
Accidental
(unintentional)
Poisoning
Accidental
(self-harm)
Poisoning
Assault
Poisoning
Undetermined
Adverse
effect
Underdosing
AcipimoxT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Antiarteriosclerotic drugT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Anticholesterolemic drug NECT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Antihyperlipidemic drugT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Antilipemic drug NECT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
BenfluorexT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
BenzalbutyramideT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
b-benzalbutyramideT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
b-sitosterol (s)T46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
BezafibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
BinifibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Cholesterol-lowering agentsT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Cholestyramine (resin)T46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
CiprofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ClinofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ClofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ClofibrideT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Clotibric acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ColestipolT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ColestyramineT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Cyamopsis tetragono-lobaT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
DetaxtranT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Ethylparachlorophen-oxyisobutyrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
EtiroxateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
EtofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
FenofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
GemfibrozilT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Guar gum (medicinal)T46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
HalofenateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Linoleic acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Linolenic acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
LovastatinT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
MesoglycanT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Oleic acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
PirozadilT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Polidexide (sulfate)T46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
PravastatinT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ProbucolT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
RonifibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Safflower oilT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
SimfibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
SimvastatinT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
SitosterolsT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
SoysterolT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Sunflower seed oilT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
TriparanolT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Unsaturated fatty acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6

Patient Education


Poisoning

A poison is any substance that is harmful to your body. You might swallow it, inhale it, inject it, or absorb it through your skin. Any substance can be poisonous if too much is taken. Poisons can include:

  • Prescription or over-the-counter medicines taken in doses that are too high
  • Overdoses of illegal drugs
  • Carbon monoxide from gas appliances
  • Household products, such as laundry powder or furniture polish
  • Pesticides
  • Indoor or outdoor plants
  • Metals such as lead and mercury

The effects of poisoning range from short-term illness to brain damage, coma, and death. To prevent poisoning it is important to use and store products exactly as their labels say. Keep dangerous products where children can't get to them. Treatment for poisoning depends on the type of poison. If you suspect someone has been poisoned, call your local poison control center at 1-800-222-1222 right away.


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.